全球脓毒症治疗市场规模、份额、趋势和成长分析报告（2026-2034年）

预计败血症治疗市场将从 2025 年的 72.2 亿美元成长到 2034 年的 131.3 亿美元，2026 年至 2034 年的复合年增长率为 6.87%。

由于严重感染疾病的增加以及人们对脓毒症作为一种危及生命的疾病的认识不断提高，全球脓毒症治疗市场正稳步增长。败血症是指人体对感染的反应导致广泛的发炎和器官衰竭。早期诊断和有效治疗对于提高存活率至关重要，这也推动了对先进治疗方案的需求。

推动市场成长的关键因素包括因严重感染疾病住院人数的增加，以及医疗专业人员对早期发现败血症重要性的认识不断提高。诊断技术的进步和加护病房也促进了市场成长。此外，政府主导的旨在改善感染控制和病人安全的倡议，正在加速推广有效的败血症治疗通讯协定。

随着对新治疗方法的研究不断深入以及诊断工具的改进，脓毒症治疗市场预计将持续成长。製药公司正致力于开发标靶治疗和免疫调节疗法，以改善患者预后。由于早期疗育和重症监护在医疗保健系统中仍然至关重要，因此对有效脓毒症治疗方法的需求预计将会增加。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章：全球脓毒症治疗市场：按类型划分

• 市场分析、洞察与预测
• 严重败血症
• 败血性休克
• 需要血液净化的败血症

第五章：全球脓毒症治疗市场：依疗法分类

• 市场分析、洞察与预测
• 连续性肾臟替代疗法（CRRT）
• 间歇性血液透析
• 持续低效每日透析（SLED）
• 其他的

第六章 全球脓毒症治疗市场：依最终用户划分

• 市场分析、洞察与预测
• 医院
• 专业治疗中心
• 其他的

第七章 全球败血症治疗市场：依地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第八章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第九章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Baxter InternationalInc
  • Fresenius Medical Care AG & Co. KGaA
  • Nipro Corporation
  • Asahi Kasei
  • B. Braun Group
  • CytoSorbents Corporation
  • Medtronic Ple
  • Nikkiso CoLtd
  • Medica SPA
  • Toray Industries
  • Merck & Co.Inc

The Sepsis Treatment Market size is expected to reach USD 13.13 Billion in 2034 from USD 7.22 Billion (2025) growing at a CAGR of 6.87% during 2026-2034.

The global sepsis treatment market is growing steadily due to the increasing incidence of severe infections and the rising awareness of sepsis as a life-threatening medical condition. Sepsis occurs when the body's response to infection causes widespread inflammation and organ dysfunction. Early diagnosis and effective treatment are critical to improving survival rates, which is driving the demand for advanced therapeutic solutions.

Key drivers of the market include the growing number of hospital admissions for severe infections and increasing awareness among healthcare professionals about early sepsis detection. Advances in diagnostic technologies and improvements in intensive care unit infrastructure are also supporting market growth. In addition, government initiatives promoting better infection management and patient safety are encouraging the adoption of effective sepsis treatment protocols.

Looking ahead, the sepsis treatment market is expected to expand due to ongoing research into novel therapeutic approaches and improved diagnostic tools. Pharmaceutical companies are focusing on developing targeted therapies and immunomodulatory treatments to improve patient outcomes. As healthcare systems continue to emphasize early intervention and critical care management, demand for effective sepsis treatments is likely to grow.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type

• Severe Sepsis
• Sepsis Shock
• Sepsis in Need of Blood Purification

By Therapy

• Continuous Renal Replacement Therapies (CRRT)
• Intermittent Hemodialysis
• Sustained Low-efficiency Daily Dialysis (SLED)
• Others

By End User

• Hospitals
• Specialty Centers
• Others

COMPANIES PROFILED

• Baxter International, Inc, Fresenius Medical Care AG Co KGaA, Nipro Corporation, Asahi Kasei, B Braun Group, CytoSorbents Corporation, Medtronic ple, Nikkiso Co, Ltd, Medica SPA, Toray Industries, Merck Co, Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL SEPSIS TREATMENT MARKET: BY TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Type
• 4.2. Severe Sepsis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Sepsis Shock Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Sepsis in Need of Blood Purification Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL SEPSIS TREATMENT MARKET: BY THERAPY 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Therapy
• 5.2. Continuous Renal Replacement Therapies (CRRT) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Intermittent Hemodialysis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Sustained Low-efficiency Daily Dialysis (SLED) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL SEPSIS TREATMENT MARKET: BY END USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End User
• 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Specialty Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL SEPSIS TREATMENT MARKET: BY REGION 2022-2034 (USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Type
  • 7.2.2 By Therapy
  • 7.2.3 By End User
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Type
  • 7.3.2 By Therapy
  • 7.3.3 By End User
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Type
  • 7.4.2 By Therapy
  • 7.4.3 By End User
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Type
  • 7.5.2 By Therapy
  • 7.5.3 By End User
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Type
  • 7.6.2 By Therapy
  • 7.6.3 By End User
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL SEPSIS TREATMENT INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Baxter InternationalInc
  • 9.2.2 Fresenius Medical Care AG & Co. KGaA
  • 9.2.3 Nipro Corporation
  • 9.2.4 Asahi Kasei
  • 9.2.5 B. Braun Group
  • 9.2.6 CytoSorbents Corporation
  • 9.2.7 Medtronic Ple
  • 9.2.8 Nikkiso CoLtd
  • 9.2.9 Medica SPA
  • 9.2.10 Toray Industries
  • 9.2.11 Merck & Co.Inc